This setup has the 20 crossing the 50 ema, and the price crossing above the 180....nice stet-up for swing traders, from a good solid company with expected forward growth and a nice dividend yield; I like it!
"For Bristol-Myers, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.38%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Bristol-Myers will most likely beat the consensus EPS estimate." (Zacks)
"For Bristol-Myers, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.38%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Bristol-Myers will most likely beat the consensus EPS estimate." (Zacks)